Prevalence and clinical manifestations of shiga toxin-producingEscherichia coli infections in Austrian children
- 1 July 1996
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 15 (7) , 545-550
- https://doi.org/10.1007/bf01709361
Abstract
The prevalence and clinical manifestations of infections associated with Shiga toxin-producingEscherichia coli (STEC) among Austrian children were assessed. Stool samples from 280 pediatric patients were analyzed by enzyme immunoassay (EIA) for the presence of free fecal Shiga toxin (Stx) 1 and 2, and by culture on sorbitol MacConkey agar. Specimens testing positive by the EIA were subjected to a cytotoxicity assay, polymerase chain reaction analysis, and a colony hybridization test. Direct culture on MacConkey agar demonstrated the presence of threeEscherichia coli O157:H7-positive stools. These were also positive by EIA and by the DNA-based methods. An additional six samples were positive by EIA, and in four of these, non-O157 STEC of serotypes O111H−, O146: H−, and O113:H53 could be isolated. Analysis of stools for a variety of enteric pathogens demonstrated that STEC was the third most common bacterial pathogen. The clinical manifestations of STEC infections were difficult to distinguish from those of infections caused by other enteric pathogens, as most patients presented with watery diarrhea. The median age of children with STEC infections was 27.6 months (range, 7 months to 5.75 years); children withSalmonella orCampylobacter infections were younger on average, while those withRotavirus infections were older. This study demonstrated that althoughEscherichia coli O157:H7 could be identified with the same sensitivity by both EIA or agar-based methods, the identification of non-O157 STEC strains was enhanced by the use of EIA followed by colony hybridization. Analysis of overnight cultures from 53 STEC isolates revealed that all strains producing Stx1, Stx2, or Stx2c reacted in the EIA. However, culture supernatants from Stx2e-producingEscherichia coli O101 were negative in the EIA. Despite this disadvantage, the EIA is easy to perform and time efficient and can be recommended as a screening test for non-O157 STEC in children with diarrhea.Keywords
This publication has 40 references indexed in Scilit:
- Pheno-genotyping of verotoxin 2 (VT2)-producing Escherichia coli causing haemorrhagic colitis and haemolytic uraemic syndrome by direct analysis of patients' stoolsJournal of Medical Microbiology, 1995
- Prevalence of attaching and effacing escherichia coli in stool samples from patients and controlsZentralblatt für Bakteriologie, 1994
- A Prospective Study of Shiga-Like Toxin-Associated Diarrhea in a Pediatric PopulationJournal of Pediatric Gastroenterology and Nutrition, 1994
- Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndromeJournal of Medical Microbiology, 1994
- Communitywide Outbreak of Hemolytic-Uremic Syndrome Associated with Non-O157 Verocytotoxin-Producing Escherichia coliThe Journal of Infectious Diseases, 1994
- Occurrence and phenotypic properties of verotoxin producingEscherichia coli in sporadic cases of gastroenteritisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- A Biotyping Scheme for Shiga-like (Vero) Toxin-producing Escherichia coli 0157 and a List of Serological Cross-reactions Between O157 and Other Gram-negative Bacteria'sZentralblatt für Bakteriologie, 1992
- Serological and Biochemical Properties of Shiga-like Toxin (Verocytotoxin)-Producing Strains of Escherichia coli, Other than O-Group 157, from Patients in GermanyZentralblatt für Bakteriologie, 1992
- High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndromeThe Journal of Pediatrics, 1991
- Results of a 6-Month Survey of Stool Cultures for Escherichia coli O157:H7Mayo Clinic Proceedings, 1990